Winzeler B, da Conceio I, Refardt J, Sailer CO, Dutilh G, Christ-Crain M (2019) Effects of glucagon-like peptide-1 receptor agonists on hypothalamic-pituitary-adrenal axis in healthy volunteers
The mechanism is fascinating and highly specific to lupus pathology
PlexusDx partners exclusively with licensed 503A compounding pharmacies that follow strict quality standards for preparation, sterility, and appearance consistency
GLP-1 receptor agonists work by mimicking the action of endogenous GLP-1, a hormone that stimulates insulin secretion in a glucose-dependent manner, suppresses glucagon release, slows gastric emptying, and promotes satiety through central nervous system pathways
In 24 weeks: Participants lost an average of 5% of their starting weight on the highest dose
FDAs statement was not limited to Hims & Hers